Atlas Trials

Head and Neck Squamous Cell Carcinoma (HNSCC)

56 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Head and Neck Squamous Cell Carcinoma (HNSCC)

RecordFirmDate
RBD-HPV: Risk-Based De-Intensification for HPV+ HNSCC (NCT04849377)Icahn School of Medicine at Mount Sinai2022-06-14
A Study to Test Whether Different Combinations of BI 765063, Ezabenlimab, Chemotherapy, Cetuximab, and BI 836880 Help People With Head and Neck Cancer or Liver Cancer (NCT05249426)Boehringer Ingelheim2022-04-12
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors (NCT05176483)Exelixis2021-12-14
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing (NCT04981119)A2 Biotherapeutics Inc.2021-10-29
A Study of TransCon TLR7/8 Agonist With or Without Pembrolizumab in Patients With Advanced or Metastatic Solid Tumors (NCT04799054)Ascendis Pharma Oncology Division A/S2021-03-18
A Study for Identification of Immune Determinants for Response to Nivolumab in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma (NCT04603248)Yonsei University2020-12-03
Study of Intratumoral (IT) Ulevostinag (MK-1454) in Combination With Intravenous (IV) Pembrolizumab (MK-3475) Compared to IV Pembrolizumab Alone as the First Line Treatment of Metastatic or Unresectable, Recurrent Head and Neck Squamous Cell Carcinoma (HNSCC) (MK-1454-002) (NCT04220866)Merck Sharp & Dohme LLC2020-03-04
Study of Safety and Tolerability of Nivolumab Treatment Alone or in Combination With Relatlimab or Ipilimumab in Head and Neck Cancer (NCT04080804)Dan Zandberg2019-12-20
GEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid Tumors (NCT04083599)Genmab2019-09-17
Pembrolizumab and Induction Chemotherapy in Head and Neck Squamous Cell Carcinoma (PICH Study) (NCT03114280)Centre Antoine Lacassagne2019-03-12
A Phase 1 Study of [225Ac]-FPI-1434 Injection (NCT03746431)Fusion Pharmaceuticals Inc.2019-01-17
A Multiple Ascending Dose Study of MEDI7247 in Advanced or Metastatic Solid Tumors (NCT03811652)MedImmune LLC2018-12-20
An Study to Evaluate the Safety and Efficacy of Copanlisib in Combination With Nivolumab in Patients With Advanced Solid Tumors (NCT03735628)Bayer2018-10-17
Effects of Avmacol® in the Oral Mucosa of Patients Following Curative Treatment for Tobacco-related Head and Neck Cancer (NCT03268993)University of Pittsburgh2018-07-27
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma (NCT03556228)VM Oncology, LLC2018-06-08
A Clinical and Biological Umbrella Protocol for Smoker or Non-smoker Patients With OPML or HNSCC (NCT03276819)Centre Leon Berard2018-02-01
Biological Vaccine: Semi-allogeneic Human Fibroblasts (MRC-5) Transfected With DNA (NCT02211027)Robert Ferris2016-09-01
Safety Testing of Adding Nivolumab to Chemotherapy in Patients With Intermediate and High-Risk Local-Regionally Advanced Head and Neck Cancer (NCT02764593)RTOG Foundation, Inc.2016-06-01
Screening Trial of Nivolumab With Image Guided, Stereotactic Body Radiotherapy (SBRT) Versus Nivolumab Alone in Patients With Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC) (NCT02684253)Memorial Sloan Kettering Cancer Center2016-02-11
Evaluation of Sentinel Lymph Nodes in Head and Neck Squamous Cell Carcinoma (NCT00911326)Navidea Biopharmaceuticals2009-05-01

Track Head and Neck Squamous Cell Carcinoma (HNSCC) automatically

Every clearance here is in the API, with alerts when new ones post.